HIV-infected individuals are at high risk for abnormal glucose metabolism, speculated to be
multifactorial in etiology, including, but not limited to, the effects of HIV infection itself …

Since the introduction of highly active antiretroviral therapy (HAART) more than a decade
ago, there has been a dramatic improvement in the morbidity and mortality associated with …

Treatment of human immunodeficiency virus-1 (HIV-1) infection with highly active
antiretroviral therapy (HAART) has become increasingly effective in controlling this life …

The introduction of highly active antiretroviral therapy (HAART) has dramatically improved
the long-term prognosis of human immunodeficiency virus (HIV)–infected patients, but …

The contribution of current antiretroviral treatment regimens to the long-term survival of HIV-
infected individuals is accompanied by increased risk of glucose metabolism abnormalities …

OBJECTIVE: To review the impact that factors such as HIV infection, antiretrovirals, and
other commonly used drug therapies have on glucose metabolism in HIV-infected patients …

HIV-associated morbidity and mortality have declined significantly since the introduction of
highly active antiretroviral therapy (HAART). These developments have allowed an …

Patients with HIV can now expect an improved life expectancy following the introduction of
combined antiretroviral therapy. However, patients with HIV are at risk of developing …

People living with HIV (PLWH) are living longer and also have unique risk factors for
developing several metabolic diseases, including diabetes. This has been observed in both …

Aims To examine incidence density rate and correlates of incident diabetes mellitus in a
cohort of HIV‐infected individuals compared with matched non‐HIV‐infected persons …